Clinical Trial Update: Pediatric Study to Evaluate Risk of Developing Essential Fatty Acid Deficiency When Receiving Clinolipid or Standard-of-Care Lipid Emulsion [Phase 4]

View source ↗

Summary

Phase 4 pediatric trial assessing risk of essential fatty acid deficiency with Clinolipid or standard lipid emulsion; study terminated, results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Fatty Acids Deficiency

Drugs mentioned

• CLINOLIPID (Olive Oil and Soybean Oil)

Snippet

Sponsor: Baxter Healthcare Corporation | Conditions: Essential Fatty Acid Deficiency (EFAD) | Phase 4 | Status: TERMINATED | Results posted: 2017-12-05